Literature DB >> 21540856

Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.

Margarita Dominguez-Villar1, Clare M Baecher-Allan, David A Hafler.   

Abstract

CD4(+)CD25(high)CD127(low/-) forkhead box p3 (Foxp3)(+) regulatory T cells (T(reg) cells) possess functional plasticity. Here we describe a higher frequency of T helper type 1 (T(H)1)-like, interferon-γ (IFN-γ)-secreting Foxp3(+) T cells in untreated subjects with relapsing remitting multiple sclerosis (RRMS) as compared to healthy control individuals. In subjects treated with IFN-β, the frequency of IFN-γ(+)Foxp3(+) T cells is similar to that in healthy control subjects. In vitro, human T(reg) cells from healthy subjects acquire a T(H)1-like phenotype when cultured in the presence of interleukin-12 (IL-12). T(H)1-like T(reg) cells show reduced suppressive activity in vitro, which can partially be reversed by IFN-γ-specific antibodies or by removal of IL-12.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540856      PMCID: PMC3675886          DOI: 10.1038/nm.2389

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  15 in total

1.  Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.

Authors:  A Rabinovitch; W L Suarez-Pinzon; O Sorensen
Journal:  J Autoimmun       Date:  1996-10       Impact factor: 7.094

2.  T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects.

Authors:  Kristin M Beima; Michael M Miazgowicz; Megan D Lewis; Pearlly S Yan; Tim H-M Huang; Amy S Weinmann
Journal:  J Biol Chem       Date:  2006-02-10       Impact factor: 5.157

3.  CCR5 is characteristic of Th1 lymphocytes.

Authors:  P Loetscher; M Uguccioni; L Bordoli; M Baggiolini; B Moser; C Chizzolini; J M Dayer
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

4.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.

Authors:  Manoj Kumar; Norman Putzki; Volker Limmroth; Ralph Remus; Monika Lindemann; Dietmar Knop; Norbert Mueller; Cornelia Hardt; Ernst Kreuzfelder; Hans Grosse-Wilde
Journal:  J Neuroimmunol       Date:  2006-09-29       Impact factor: 3.478

6.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D A Hafler; D A Fox; M E Manning; S F Schlossman; E L Reinherz; H L Weiner
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

7.  Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.

Authors:  Anne L Astier; Gregory Meiffren; Samuel Freeman; David A Hafler
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

8.  Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production.

Authors:  Adriana A Byrnes; Justin C McArthur; Christopher L Karp
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

Review 9.  Multiple sclerosis: a complicated picture of autoimmunity.

Authors:  Henry F McFarland; Roland Martin
Journal:  Nat Immunol       Date:  2007-09       Impact factor: 25.606

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  198 in total

1.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.

Authors:  Thomas Duhen; Rebekka Duhen; Antonio Lanzavecchia; Federica Sallusto; Daniel J Campbell
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

Review 2.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

4.  TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Authors:  Pamela A Frischmeyer-Guerrerio; Anthony L Guerrerio; Gretchen Oswald; Kristin Chichester; Loretha Myers; Marc K Halushka; Maria Oliva-Hemker; Robert A Wood; Harry C Dietz
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

5.  Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.

Authors:  Nicolas Thiault; Julie Darrigues; Véronique Adoue; Marine Gros; Bénédicte Binet; Corine Perals; Bertrand Leobon; Nicolas Fazilleau; Olivier P Joffre; Ellen A Robey; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Nat Immunol       Date:  2015-05-04       Impact factor: 25.606

6.  Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting.

Authors:  Coleman Murray; Hiromi Miwa; Manjima Dhar; Da Eun Park; Edward Pao; Jessica Martinez; Sireesha Kaanumale; Evelina Loghin; John Graf; Khadir Raddassi; William W Kwok; David Hafler; Chris Puleo; Dino Di Carlo
Journal:  Lab Chip       Date:  2018-08-07       Impact factor: 6.799

Review 7.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

8.  Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.

Authors:  Nalini K Vudattu; Klemen Strle; Allen C Steere; Elise E Drouin
Journal:  Arthritis Rheum       Date:  2013-06

9.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

10.  Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Vaidehi R Chowdhary; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.